Revenue - Bergenbio ASA (OSE:BGBIO) - Alpha Spread
B

Bergenbio ASA
OSE:BGBIO

Watchlist Manager
Bergenbio ASA
OSE:BGBIO
Watchlist
Price: 9.07 NOK 1.06% Market Closed
Market Cap: 368.3m NOK
Have any thoughts about
Bergenbio ASA?
Write Note

Bergenbio ASA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bergenbio ASA
Revenue Peer Comparison

Comparables:
HBC
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
B
Bergenbio ASA
OSE:BGBIO
Revenue
kr521k
CAGR 3-Years
-5%
CAGR 5-Years
-46%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Revenue
kr226.1m
CAGR 3-Years
50%
CAGR 5-Years
30%
CAGR 10-Years
14%
L
Lytix Biopharma AS
OSE:LYTIX
Revenue
kr4m
CAGR 3-Years
N/A
CAGR 5-Years
64%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Revenue
kr117.7m
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
19%
N
Nykode Therapeutics ASA
OSE:NYKD
Revenue
$10.6m
CAGR 3-Years
-63%
CAGR 5-Years
267%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Revenue
kr800k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
10%

See Also

What is Bergenbio ASA's Revenue?
Revenue
521k NOK

Based on the financial report for Mar 31, 2024, Bergenbio ASA's Revenue amounts to 521k NOK.

What is Bergenbio ASA's Revenue growth rate?
Revenue CAGR 5Y
-46%

Over the last year, the Revenue growth was 34%. The average annual Revenue growth rates for Bergenbio ASA have been -5% over the past three years , -46% over the past five years .

Back to Top